Stable antibody formulations

Details for Australian Patent Application No. 2007307107 (hide)

Owner Amgen Inc.

Inventors McAuley, Arnold; Rehder, Douglas; Matsumura, Masazumi

Agent Wrays

Pub. Number AU-B-2007307107

PCT Pub. Number WO2008/045373

Priority 60/850,970 10.10.06 US; 60/850,362 06.10.06 US

Filing date 5 October 2007

Wipo publication date 17 April 2008

Acceptance publication date 3 November 2011

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/5377 (2006.01)

Event Publications

14 May 2009 PCT application entered the National Phase

  PCT publication WO2008/045373 Priority application(s): WO2008/045373

3 November 2011 Application Accepted

  Published as AU-B-2007307107

1 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007307111-High-purity large-scale preparation of stannsoporfin

2007307105-N-substituted-azacyclylamines as histamine-3 antagonists